Reengagement and Retention in HIV Care to End the HIV Epidemic in Rural and Underserved Communities: An Interdisciplinary Team Approach
March 15, 2023
March 15, 2024
This activity is provided by Talem Health and RME Collaborative.
In collaboration with:
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
- Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
- Nurses — 1.5 Contact Hours (0.25 contact hour of pharmacotherapy credit)
- Pharmacists — 1.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is designed specifically for primary care clinicians, nurses, pharmacists, and other members of the healthcare team who serve patients in rural and underserved communities.
Approximately 1.1 million individuals are living with HIV in the United States, yet only about 50% are retained in care. Failure to engage with care is associated with poorer health outcomes and a higher risk of HIV transmission. In rural and underserved communities, particularly those in the Southeast, the burden of HIV is disproportionately high. Individuals who reside in these areas also face significant barriers to care—including stigma, clinician shortages, long travel distances to care, and poverty—that exacerbate the problem. Thus, strategies to ensure these patients continue their HIV care are urgently needed. In this activity, a multidisciplinary panel featuring a physician, social worker, and peer educator will share perspectives and discuss evidence-based interventions to identify, reengage, and retain people with HIV in care. Best practices for providing individualized, guideline-based treatment to patients living with HIV will also be reviewed as part of the conversation.
This activity was recorded from a live webcast on January 27, 2023. Please note that data, information, and guidance presented in the video are subject to change.
Upon completion of this activity, participants should be better able to:
- Employ evidence-based interventions to identify, reengage, and retain people with HIV in care
- Examine factors that impact antiretroviral therapy selection in patients with HIV such as adherence, resistance potential, and safety
- Apply current evidence and guideline recommendations to individualize HIV treatment and meet the clinical and social needs of the patient
- Incorporate evidence-based strategies to improve multidisciplinary management and engagement in HIV care in rural and underserved communities
Onyema E. Ogbuagu, MD, FACP, FIDSA
Associate Professor of Medicine
Director, HIV Clinical Trials Program
Yale AIDS Program, Section of Infectious Diseases
Yale School of Medicine
Attending Physician, Infectious Diseases
Yale-New Haven Health, Yale Medicine
New Haven, CT
Raven O’Rourke, LCSW, MPH
Social Work Team Lead
Vanderbilt Comprehensive Care Clinic
Tiye Link, EdD, MS, MBA
Program Director, Healthy University
Joint Accreditation Statement
In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Talem Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 0.25 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
Continuing Pharmacy Education
Talem Health designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008332-0000-23-002-H01-P)
Type of Activity: Application
Disclosure of Conflicts of Interest
Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
All relevant financial relationships have been mitigated.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Onyema E. Ogbuagu, MD, FACP, FIDSA, has disclosed the following relevant financial relationships: consultant/advisory board member for Gilead Sciences, Inc., Janssen Pharmaceuticals, and ViiV Healthcare; speakers’ bureau/honoraria from Gilead Sciences, Inc.
Raven O’Rourke, LCSW, MPH, has no relevant financial relationships to disclose.
Tiye Link, EdD, MS, MBA, has no relevant financial relationships to disclose.
Planners, Managers, and Reviewer
The Talem Health planners, managers, and reviewer have nothing to disclose.
Instructions for Participation and Credit
This activity is offered at no cost to participants. To receive CME credit, participants must:
- Read the CME/CE information, including learning objectives and disclosure statements.
- Complete the pre-test.
- View the online activity.
- Complete the post-test and evaluation form.
A post-test score of 67% or higher is required to obtain credit. Your certificate will be made available for immediate download.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.
There is no fee for this educational activity.
For questions about this activity, please contact RME Collaborative (a division of Talem Health) at 800-913-9370 or firstname.lastname@example.org.